Company: INDP
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001493152-25-010136
Chunk: 703

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 4
Chunk 703
---
8/4/2031

    01/26/22
     
    (3)

    42,029

    3,821

    —

    4.90

    01/26/32

    01/18/23
     
    (4)

    23,333

    16,667

    —

    1.61

    01/18/33

    01/22/24
     
    (5)

    —

    75,000

    —

    1.74

    01/22/34

    10/09/24
     
    (6)

    —

    75,000

    —

    1.105

    10/09/34
  
    Roger
    J. Waltzman, Chief Medical Officer

    08/07/23
     
    (7)

    37,500

    52,500

    —

    1.85

    08/07/33

    01/22/24
     
    (5)

    —

    75,000

    —

    1.74

    01/22/34

    10/09/24
     
    (6)

    —

    75,000

    —

    1.105

    10/09/34

(1)
The options have a seven-year term or ten-year term as noted in the table subject to earlier expiration upon termination.

(2)
The options vest over a period of three years from August 4, 2021, 33.3% on the first anniversary of such date and 8.33% every three
months thereafter, ending August 4, 2024.

(3)
The options vest over a period of three years from January 26, 2022, 33.3% on the first anniversary of such date and 8.33% every three
months thereafter, ending January 26, 2025.

(4)
The options vest over a period of three years from January 18, 2023, 33.3% on the first anniversary of such date and 8.33% every three
months thereafter, ending January 18, 2026.

(5)
The options vest over a period of three years from January 22, 2024, 33.3%